Monday, June 15, 2026

US-South Korean Air Forces Intercept Virtual North Korean Cruise Missiles and Drop Bombs on Long-Range Artillery Positions

The US and South Korean air forces have enhanced their precision strike capabilities by conducting live-fire training exercises.

SHADOW AGENTS: South Korea Uses Defector Brokers As Secret Money Channels To The North

North Korean defectors face legal scrutiny over sending money home, with recent court rulings highlighting the need for clearer regulations.

K-Beauty Takes the U.S.: How Korean Derma-Cosmetics Are Expanding in 2026

South Korean pharmaceutical firms are expanding into the U.S. dermacosmetics market, leveraging online success for offline growth.

Tag: SK Biopharmaceuticals

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

SK Biopharmaceuticals Unveils Breakthrough Findings on NTSR1-Targeted Radiopharmaceutical SKL35501

SK Biopharmaceuticals will present findings on NTSR1-targeted treatments at the AACR Annual Meeting, showcasing innovative oncology research.

SK Biopharmaceuticals Selects Two CNS Startups Through Open Innovation… Advances Expected in Parkinson’s and Alzheimer’s Treatment

SK Biopharmaceuticals partners with Seoul Bio Hub to support two CNS startups, Novorex and Threebrooks, in innovative drug development.

Exploring Cenobamate: How SK Biopharmaceuticals’ New Oral Suspension Benefits Adult Epilepsy Patients

SK Biopharmaceuticals submits NDA for Cenobamate oral suspension, enhancing treatment options for epilepsy patients with swallowing difficulties.

SK Biofarm, FDA Approved Radioactive Method: Will it be a Revolutionary Cancer Cure with SLK 33501?

SK Biopharmaceuticals gains FDA approval for Phase 1 trials of radiopharmaceuticals SKL35501 and SKL35502, advancing cancer treatment.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.